Marvin L. White
Independent DirectorMr. Marvin L. White has been an Independent Director at Emergent BioSolutions Inc. since 2022 and served as its Director since October 1, 2020 until 2022. Mr. White has been Executive Chair at Aptevo Therapeutics Inc. since April 1, 2026 and as its Director since August 1, 2016. Mr. White was Chief Executive Officer and President at Aptevo Therapeutics Inc. since August 1, 2016 until April 1, 2026. He serves as Director of Delta Dental of Washington. Mr. White has been the President and Chief Executive Officer at The MLW Advisory Group, LLC since April 2014. Mr. White served as Chief Financial Officer and System Vice President at St. Vincent Hospital and Health Care Center, Inc from 2008 to March 2014. He also served as a consultant to Emergent prior to joining Aptevo. He served as Chief Financial Officer at Eli Lilly & Company's Lilly USA, LLC a subsidiary of Eli Lilly and Company, where he also held leadership positions in Corporate Finance and Investment Banking. He served leadership positions at Lilly in Corporate Finance and Investment Banking in the Corporate Strategy Group. He served as the Pharmaceutical Company's Assistant Treasurer. He served as an Executive Director of Eli Lilly & Company's LillyUSA and Lilly pharmaceutical company. Prior to his career in health care, he served with General Motors in Illinois and Hewlett Packard in Atlanta, where he served various Supervisory and financial assignments. In 1993, he joined Motorola's Cordless Operation as an Operations Controller and Senior Operations Controller for the Japan Cellular Division since 1995. He moved to Singapore in 1997 as the South Asia Divisional Controller for Motorola's Cellular Sector and served as its Latin America Divisional Controller for the Cellular sector. He served as Chairman of St. Vincent Indianapolis Hospital Board of Directors. He has been a Trustee at HealthLease Properties Real Estate Investment Trust since December 4, 2013. He has been a Director of OneAmerica Financial Insurance Partners, Inc. since September 2014. He serves as a Treasurer at Delta Dental of Washington. He serves as a Director of Ryla, Inc. He serves on the Boards of Marian University, Advantage Health Solutions, Inc. Mr. White served as an Independent Director of CoLucid Pharmaceuticals, Inc. since July 13, 2015 until March 1, 2017. From June 2014 until August 2016, Mr. White served on the Board of Directors of Washington Prime Group. He serves as an Independent Director of WP GLIMCHER Inc. from May 7, 2014. He served as a Director of Emergent BioSolutions, Inc. since June 2010 until May 26, 2016. He served as a Director of Lilly USA, LLC. He is active with the Center for Leadership Development, Saving Orphans through Healthcare and Outreach (SOHO) and with the United Way. He served as a Member of the Arts Council of Indianapolis. Mr. White received master’s degree in Business Administration in Finance from Indiana University in 1989 and Bachelor of Science in Accounting from Wilberforce University in 1984.
Positions
- Company NameEmergent BioSolutions Inc.Stock CodeEBSPositionIndependent DirectorColleagues
- JCJoseph C. PapaCEO, President & Director
- ZPZsolt P. HarsanyiIndependent Non-Executive Chairman
- RSRichard S. LindahlExecutive VP, CFO and Principal Financial & Accounting Officer
- CGColeen GlessnerExecutive Vice President of Quality, Ethics & Compliance
- PAPaul A. WilliamsSenior Vice President of Products Business
- JPJessica PerlSenior VP, Corporate Secretary & General Counsel
- MLMarvin L. WhiteIndependent Director
- STSujata T. DayalIndependent Director
- DWDonald W. DeGolyerIndependent Director
- Company NameAptevo Therapeutics Inc.Stock CodeAPVOPositionExecutive ChairColleagues
- JGJeffrey G. LamotheCEO, President & Director
- SKSoYoung KwonCorporate Secretary, Senior VP, General Counsel, Business Development & Corporate Affairs
- DLDaphne L. TaylorSenior VP & CFO
- MJMary J. JanatpourSenior VP & Chief Scientific Officer
- ZPZsolt P. HarsanyiIndependent Director
- BLBarbara Lopez KunzIndependent Director
- JEJohn E. NiederhuberLead Independent Director
